A Scientist Just Created A New Giant, Mutant Magic Mushroom
Snowball Cubensis photo via Inoculate the World
A novel psilocybin mushroom strain, ‘Snowball Cubensis,’ has garnered significant attention within the mycology and psychedelics communities. This strain distinguishes itself through its unique morphology, lacking gills and exhibiting a propensity to bruise blue upon contact. Each specimen can grow to the size of a softball, presenting as a psychoactive puffball.
New: Interested in Being Part of a Psychedelics-Focused Clinical Trial? Sign Up Here
Discovery and Development
Mycologist Pope Joseph identified Snowball Cubensis during the cultivation of a batch of Penis Envy mushrooms. Noticing a distinct mutation, he embarked on an extensive process to isolate and stabilize the strain. Over two and a half years, involving thousands of Petri dishes, he refined the strain to achieve true stability. The result is a mushroom unlike any other in the Psilocybe cubensis family.
Looking for treatment? Find ketamine clinics closest to you as well as other psychedelic therapies in your area.
Availability and Research Potential
Currently, spore syringes for cultivating ‘Snowball Cubensis’ are exclusively available through InoculateTheWorld (ITW), a Seattle-based mushroom spore distributor. ITW emphasizes the strain’s uniqueness, suggesting it as an ideal addition for researchers seeking novel and exciting subjects. The company also offers other strains, including Golden Teacher, Blue Meanie, and Stargazer, and provides a blog covering various mycology topics.
Contributions to Psychedelic Research
Andrew Collins, founder of ITW, extends his influence into the field of psychedelic therapeutics. He serves as a Managing Partner at 5DG Therapeutics, a biotech company based at the McKnight Brain Institute at the University of Florida. The company focuses on investigating psychedelic treatments for brain health disorders, particularly psilocybin. 5DG Therapeutics has partnered with Casa Sollievo della Sofferenza, a private scientific research hospital in Italy. Dr. Brent Reynolds, the company’s Chief Science Officer, has developed a patent-pending system designed to bypass peripheral metabolism and the blood-brain barrier, delivering drugs directly to the central nervous system. Reynolds is renowned for his stem cell research and has been a professor at the University of Florida for 17 years.
The emergence of ‘Snowball Cubensis’ underscores the ongoing innovation within mycology and psychedelic research. Its unique characteristics not only captivate enthusiasts but also offer promising avenues for scientific exploration.
Learn More About Magic Mushrooms Strains
Interested in learning more about the different varieties of magic mushrooms strains? Click through our menu below for a deeper dive into each strain.
